Dr. Jeffrey L. Vacirca, MD

  • Port Jefferson, NY
  • Hematologist and oncologist
NPI1366446726PAC ID7517958762
Medicare services, 2020
4,561
Part D claims, 2024
11
Publications
16
Clinical trials
6
Hospital affiliations
1
Practice address
75 North Country Road, Port Jefferson, NY 11777
Practice phone
Call (631) 473-1320
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Mather Hospital

Hospital · Port Jefferson, New York

See all 5 affiliations

Find Dr. Vacirca's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Jeffrey L. Vacirca is a hematologist and oncologist in Port Jefferson, New York

Dr. Vacirca practices at Mather Hospital in Port Jefferson, New York, part of Northwell Health.

Dr. Vacirca's NPI, 1366446726, was assigned on June 13, 2005. Dr. Vacirca holds New York license 222234.

NPI and contact details
Medicare PAC ID
7517958762
NPI enumeration date
June 13, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(631) 473-1320
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
54
Medical school graduation
1998

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Jeffrey L. Vacirca practices at Mather Hospital in Port Jefferson, New York

Dr. Vacirca's primary practice is Mather Hospital, at 75 North Country Road, Port Jefferson, NY 11777 in Suffolk County. The practice phone is (631) 473-1320.

  • Mather Hospital
    75 North Country Road, Port Jefferson, NY 11777 · Suffolk CountyPhone(631) 473-1320

Source: Dmand AI Affiliation Data

Dr. Jeffrey L. Vacirca is affiliated with 3 sites of care and 2 medical groups

Dr. Vacirca's primary practice is Mather Hospital in Port Jefferson, New York, part of Northwell Health. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Vacirca to 1 more group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Vacirca

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Jeffrey L. Vacirca's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vacirca practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Mather HospitalAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Vacirca practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Northwell Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Jeffrey L. Vacirca is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Vacirca's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Vacirca is licensed in New York.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 222234 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Vacirca

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Jeffrey L. Vacirca billed Medicare for 4,561 services in 2020

CMS data shows 4,561 Medicare services from Dr. Vacirca across 29 procedure codes in 2020. Medicare paid $89,608 for them. Every service was in an office.

Medicare services, 20204,561
Paid by Medicare$89,608
Procedure codes29

Dr. Vacirca's Medicare services by type, 2019 to 2020

  • 2019
  • 2020
Drugs given in the office
2019: 30,0292020: 1,77094%
Lab and pathology
2019: 17,3782020: 1,62991%
Office and hospital visits
2019: 2,4422020: 95661%
Surgery
2019: 1,1992020: 13489%
Tests and treatments
2019: 1,0112020: 7293%
Other services
2019: 2532020: 0100%

Dr. Vacirca compared with the New York median for hematologists and oncologists, 2020

  • Dr. Vacirca
  • New York median
Medicare services
4,561vs 6686.8 times
Part D claims
11vs 25896% below

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Vacirca's most billed Medicare procedure codes, 2020

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vacirca

Need commercial claims for Dr. Vacirca?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vacirca and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Jeffrey L. Vacirca's patients have a median age of 57

Across all payers, Dmand AI patient panel data puts Dr. Vacirca's median patient age at 57, with 58% women.

Dr. Vacirca's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 57

Patient panel by sex, all payers

  • Women58%
  • Men42%

Source: Dmand AI Patient Panel Data

Dr. Jeffrey L. Vacirca wrote 11 Medicare Part D claims in 2024

In 2024, Dr. Vacirca wrote 11 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $89 in total drug cost. In 2021, CMS named 12 claims across 1 drug.

Part D claims, 202411
Drugs named by CMS1
Total drug cost$89

Dr. Vacirca's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 122022: 118%

Drugs named by CMS: 1 in 2022, 1 in 2021.

See all prescribing by Dr. Vacirca

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Jeffrey L. Vacirca takes part in Medicare

Dr. Vacirca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Vacirca by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Jeffrey L. Vacirca has 16 publications on record

Dmand AI links 16 papers to Dr. Vacirca, published from 2013 to 2020. 2018 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Antiemetics. Dr. Vacirca's most frequent co-authors are Lee S. Schwartzberg, MD, Richy Agajanian, MD and Minsig Choi, MD.

Papers16
Years published2013 to 2020

Dr. Vacirca's papers by year, 2013 to 2020

Topics Dr. Vacirca writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Antiemetics
  • Breast Neoplasms
  • Nausea
  • Vomiting

Dr. Vacirca's most frequent co-authors

Recent publications by Dr. Vacirca

See all 16 publications and co-authors

See who Dr. Vacirca researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vacirca works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Jeffrey L. Vacirca has worked on 6 clinical trials

Dmand AI links Dr. Vacirca to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Breast Neoplasms.

Clinical trials with Dr. Vacirca by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Vacirca's trials

  • Prostatic Neoplasms
  • Prostatic Diseases
  • Breast Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Lymphoma, Follicular

Investigators on the most trials with Dr. Vacirca

Recent clinical trials with Dr. Vacirca

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Jeffrey L. Vacirca received $255,071 in industry payments from 2016 to 2024

CMS Open Payments shows 116 general payments to Dr. Vacirca from 37 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 72% of the total. Spectrum Pharmaceuticals Inc. paid the most, $226,628. It also lists 1 research payment totaling $2,513 in 2016.

General payments to Dr. Vacirca by program year, 2016 to 2024

General payments to Dr. Vacirca by kind, 2016 to 2024

$255.1Kin total
  • Speaker and faculty fees$183,05772%
  • Consulting fees$53,57521%
  • Travel and lodging$8,0383%
  • Food and beverage$7,0563%
  • Other$3,3451%

Companies that paid Dr. Vacirca the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Vacirca

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Jeffrey L. Vacirca's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Jeffrey L. Vacirca

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Jeffrey L. Vacirca's NPI number?

Dr. Jeffrey L. Vacirca's NPI number is 1366446726. It was assigned on June 13, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Jeffrey L. Vacirca?

Dr. Jeffrey L. Vacirca is a hematologist and oncologist in Port Jefferson, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Jeffrey L. Vacirca practice?

Dr. Vacirca practices at 75 North Country Road, Port Jefferson, NY 11777. Dr. Vacirca's primary practice is Mather Hospital in Port Jefferson, New York, part of Northwell Health. Dmand AI also links Dr. Vacirca to 1 group practice or clinic, 1 skilled nursing facility and 1 medical group.

What is Dr. Jeffrey L. Vacirca's office phone number?

The practice phone on file for Dr. Vacirca is (631) 473-1320.

What is Dr. Jeffrey L. Vacirca's medical license number?

Dr. Vacirca holds New York license 222234.

Which hospitals is Dr. Jeffrey L. Vacirca affiliated with?

Dr. Vacirca practices at Mather Hospital in Port Jefferson, New York.

What medical group is Dr. Jeffrey L. Vacirca part of?

Dr. Vacirca is linked to New York Cancer & Blood Specialists. Dmand AI links Dr. Vacirca to 1 more medical group.

Does Dr. Jeffrey L. Vacirca accept Medicare?

Yes. CMS data shows Dr. Vacirca billed Medicare for 4,561 services in 2020, and Dr. Vacirca accepts Medicare assignment.

What services does Dr. Jeffrey L. Vacirca bill to Medicare?

In 2020, Dr. Vacirca's most billed Medicare services were injected or infused drug (J0897), care management and other visits (99490) and lab and pathology test (88185).

What drugs does Dr. Jeffrey L. Vacirca prescribe most?

In 2022 Medicare Part D data, Dr. Vacirca's most prescribed drugs by claims were Oxycodone-Acetaminophen.

Show 4 more questionsShow fewer questions

Has Dr. Jeffrey L. Vacirca received payments from drug or device companies?

CMS Open Payments shows $255,071 in general payments to Dr. Vacirca from 37 companies from 2016 to 2024. The largest total came from Spectrum Pharmaceuticals Inc.

How long has Dr. Jeffrey L. Vacirca been practicing?

Dr. Vacirca graduated from medical school in 1998, 28 years ago.

Does Dr. Jeffrey L. Vacirca do research?

Dmand AI links 16 publications to Dr. Vacirca, published from 2013 to 2020. Dr. Vacirca has worked on 6 clinical trials.

Who does Dr. Jeffrey L. Vacirca publish with?

Dr. Vacirca's most frequent co-authors are Lee S. Schwartzberg, MD (4 shared papers), Richy Agajanian, MD (3 shared papers) and Minsig Choi, MD (2 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)